These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6687971

  • 1. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
    Epstein S, Meunier PJ, Lambert PW, Stern PH, Bell NH.
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW, Hollis BW, Bell NH, Epstein S.
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 4. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
    Breslau NA, Moses AM, Pak CY.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
    [Abstract] [Full Text] [Related]

  • 5. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
    Unakami H.
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar 20; 58(3):234-47. PubMed ID: 6980145
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O, Xing XP, Meng XW, Xia WB, Li M, Jiang Y, Hu YY, Liu HC.
    Chin Med J (Engl); 2009 Feb 05; 122(3):279-83. PubMed ID: 19236804
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb 05; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 8. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K, Furukawa Y, Miura R, Yumita S, Sohn HE, Yoshinaga K.
    J Clin Invest; 1988 Sep 05; 82(3):861-5. PubMed ID: 2843573
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
    Unakami H, Furukawa Y, Sohn HE, Yumita S, Miura R, Hanew K, Yoshinaga K.
    Tohoku J Exp Med; 1982 Oct 05; 138(2):167-75. PubMed ID: 6294914
    [Abstract] [Full Text] [Related]

  • 10. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease.
    Davies M, Heys SE, Selby PL, Berry JL, Mawer EB.
    J Clin Endocrinol Metab; 1997 Jan 05; 82(1):209-12. PubMed ID: 8989260
    [Abstract] [Full Text] [Related]

  • 11. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE, Drezner MK, Hamdan JA, Mange M, Ahmad MS, Mubarak S, Nyhan WL.
    J Pediatr; 1986 Dec 05; 109(6):994-1000. PubMed ID: 3023599
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
    Stamp TC.
    Curr Med Res Opin; 1981 Dec 05; 7(5):316-36. PubMed ID: 6894416
    [Abstract] [Full Text] [Related]

  • 14. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT.
    J Bone Miner Res; 2007 Jun 05; 22(6):931-7. PubMed ID: 17352646
    [Abstract] [Full Text] [Related]

  • 15. 25-Hydroxyvitamin D3 loading test in primary hyperparathyroidism, hypoparathyroidism and pseudohypoparathyroidism.
    Miura R, Furukawa Y, Yumita S, Sohn HE, Mizunashi K, Yoshinaga K.
    Endocrinol Jpn; 1987 Feb 05; 34(1):97-104. PubMed ID: 3608916
    [Abstract] [Full Text] [Related]

  • 16. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Miura R, Yumita S, Yoshinaga K, Furukawa Y.
    Calcif Tissue Int; 1990 May 05; 46(5):309-13. PubMed ID: 2159833
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Endocrinology; 1982 Sep 05; 111(3):904-11. PubMed ID: 6896684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC, Young RB, Hartenberg MA, Chinchilli VM.
    J Pediatr; 1985 Mar 05; 106(3):421-6. PubMed ID: 3838346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.